Additional strategies have been developed to shield CAR T cells from inhibitory signals of the tumor microenvironment such as the co-expression of a dominant-negative receptor (DNR) for transforming growth factor beta (TGF-β) [37,38,39,40]. Here, TGFB1 is linked to neoplasm.